SHORT ANSWER
What the decision comes down to
A reliable operating plan names the owner, trigger, evidence and fallback for each critical step. If the team cannot test it, it is not yet a control. This guide applies that standard to dental ai false positives: a radiograph review protocol, with particular attention to how practices can record human review and exceptions.
Start with the operating context
Clinical AI must be evaluated as a specific software function in a specific workflow. Regulatory clearance, vendor evidence and local performance are different forms of evidence.
For this guide, the decision lens is how practices can record human review and exceptions. Define those terms for the practice before requesting proposals; otherwise each supplier can answer a different question and still appear comparable.
Build an evidence packet before deciding
Keep official documentation, contract language, observed workflow and local assumptions separate. The minimum evidence packet should include:
- The exact product name and cleared indication, when applicable
- A workflow showing where clinician review occurs
- A policy for disagreements, corrections and record retention
- A local validation sample that includes difficult and negative cases
If an item is not available for the exact product, version or service package, record it as unknown. Do not fill a gap with a brand-level claim or an old demonstration.
A step-by-step practice workflow
- 01
Assign a named owner and backup owner.
- 02
Document the normal workflow and exception path.
- 03
Set a measurable review frequency.
- 04
Retain evidence that the control ran.
- 05
Test the fallback and update the procedure after each exercise.
Decision worksheet
Verify the exact package, supported configuration and written scope for Dental AI false positives.
Apply the same workflow, evidence and cost test to a radiograph review protocol.
Use the same term, location count, users, modules, implementation assumptions and exit scenario for every option.
Define who signs off, which workflow must pass and what happens when a required item fails.
Common failure modes
- Treating a regulatory clearance as proof of superiority
- Allowing overlays to become an undocumented final diagnosis
- Measuring acceptance while ignoring false positives and workflow changes
The safest response to a missing fact is a dated follow-up question. Unsupported certainty creates more risk than a visible unknown.
What to measure after implementation
A purchase decision is a hypothesis until real operating data is reviewed. Establish a baseline and monitor:
- clinician disagreement rate
- review time
- documented corrections
- patient communication and case-acceptance impact
Review the measures at 30, 90 and 180 days. Keep configuration changes and exceptional events beside the numbers so a change is not mistaken for product performance.
Questions to put in writing
- Which exact products, modules, versions and services are included?
- Which dependencies, integrations and responsibilities remain with the practice?
- What happens during an outage, failed migration or missed service level?
- Which data can be exported, in what format, on what timeline and at what cost?
- Which statement in the proposal is a contractual commitment rather than a marketing description?
PRACTICAL FAQ
Questions dental buyers ask
What is the first step for dental ai false positives: a radiograph review protocol?
Write the practice-specific outcome and the exact workflow to test. Then collect evidence for how practices can record human review and exceptions before comparing conclusions.
Can a vendor demonstration answer the decision?
A demonstration can show a possible workflow, but it does not prove the contracted scope, migration quality, local reliability or total ownership cost. Confirm those points in writing and through an acceptance test.
What should stay visible as unknown?
Any price, compatibility, performance or support claim that has not been verified for the exact product, version and practice configuration should remain labeled as unknown or vendor-stated.